Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

2473-2484 of 2541 results
Page 207 of 212
Key Publications March 9, 2009

Short sleep duration and incident coronary artery calcification.

JAMA 2008;300:2859-66

King CR, Knutson KL, Rathouz PJ, Sidney S, Liu K, Lauderdale DS
Cardiovascular Disease Clinical Cardiology Prevention
Key Publications February 6, 2009

Plasma fetuin-A levels and the risk of myocardial infarction and ischemic stroke.

Circulation 2008;118:2555-62

Weikert C, Stefan N, Schulze MB et al.
Cardiovascular Disease Metabolism: Human Studies
Key Publications January 23, 2009

CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction.

Eur Heart J 2008;29:2792-9

Regieli JJ, Jukema JW, Grobbee DE et al.
Cardiovascular Disease Genetics Lipids/Lipoproteins
Key Publications December 14, 2008

Uric acid and cardiovascular risk.

N Engl J Med 2008;359:1811-21

Feig DI, Kang DH, Johnson RJ
Cardiovascular Disease Hypertension Metabolic Syndrome
Key Publications December 10, 2008

Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors.

Diabetes Care 2008;31:2154-9

Giorda CB, Avogaro A, Maggini M et al.
Cardiovascular Disease Diabetes Epidemiology
Key Publications December 9, 2008

Distribution and cardiovascular risk correlates of hemoglobin A(1c) in nondiabetic younger adults: the Bogalusa Heart Study.

Metabolism 2008 57:1487-92

Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS
Cardiovascular Disease Diabetes Insulin Resistance
Key Publications November 12, 2008

Predictors of outcomes in low-flow, low-gradient aortic stenosis: results of the multicenter TOPAS Study.

Circulation 2008;118:S234-42

Clavel MA, Fuchs C, Burwash IG et al.
Cardiovascular Disease Clinical Cardiology Clinical Trials
Key Publications October 31, 2008

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Lancet 2008;372:807-16

Fox K, Ford I, Steg PG, Tendera M, Ferrari R, BEAUTIFUL Investigators
Cardiovascular Disease Clinical Trials
Key Publications October 30, 2008

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.

Lancet 2008;372:817-2

Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, BEAUTIFUL Investigators
Cardiovascular Disease Clinical Trials
Key Publications October 26, 2008

Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia.

Eur Heart J 2008;29:2195-201

Van der Net JB, Oosterveer DM, Versmissen J et al.
Cardiovascular Disease Genetics Lipids/Lipoproteins
Key Publications October 25, 2008

Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study.

Eur Heart J 2008;29:2244-51

Elkeles RS, Godsland IF, Feher MD et al.
Cardiovascular Disease Clinical Cardiology Prevention
Key Publications October 24, 2008

Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.

J Am Coll Cardiol 2008;52:914-20

Giraldez RR, Giugliano RP, Mohanavelu S et al.
Acute Coronary Syndromes Cardiovascular Disease Lipids/Lipoproteins
of 212